First Time Loading...

Geron Corp
NASDAQ:GERN

Watchlist Manager
Geron Corp Logo
Geron Corp
NASDAQ:GERN
Watchlist
Price: 3.81 USD -1.55% Market Closed
Updated: May 9, 2024

Geron Corp
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Geron Corp
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Geron Corp
NASDAQ:GERN
Cash from Financing Activities
$228.8m
CAGR 3-Years
8%
CAGR 5-Years
20%
CAGR 10-Years
8%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$2.2B
CAGR 3-Years
31%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.4B
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Geron Corp's Cash from Financing Activities?
Cash from Financing Activities
228.8m USD

Based on the financial report for Mar 31, 2024, Geron Corp's Cash from Financing Activities amounts to 228.8m USD.

What is Geron Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
8%

Over the last year, the Cash from Financing Activities growth was -38%. The average annual Cash from Financing Activities growth rates for Geron Corp have been 8% over the past three years , 20% over the past five years , and 8% over the past ten years .